Table 2.
Changes in BMI and body weight and baseline biochemical findings (n = 30, mean ± SD)
| Healthy controls (n = 30) |
Patients with gastric cancer |
P value (between groups) (ANOVA) | ||
| Non-cachexia (n = 30) | Cachexia (n = 30) | |||
| Initial BMI (kg/m2) | 25.3 ± 2.3 | 27 ± 5.1 | 26.3 ± 2.5 | 0.985 |
| Final BMI (kg/m2) | 26.7 ± 2.8 | 24.8 ± 5.0 | 20.3 ± 2.5a | 0.002 |
| Change BMI (%) | 1.26 ± 2.6 | -4.0 ± 2.4c | -5.7 ± 5.2a | < 0.001 |
| Initial weight (kg) | 75.4 ± 11.0 | 73.8 ± 13.3 | 70.0 ± 12.3 | 0.436 |
| Final weight (kg) | 76.2 ± 10.2 | 70.8 ± 16.3c | 53.6 ± 13.0a | 0.001 |
| Change weight (kg) | 0.15 ± 0.76 | -2.9 ± 1.5c | -10.4 ± 3.3a | < 0.001 |
| Hb (gr/L) | 12.8 ± 2.8 | 12.6 ± 1.9 | 11.1 ± 1.3a | < 0.001 |
| TSH (mIU/mL) | 1.96 ± 0.28 | 1.98 ± 0.85 | 2.11 ± 0.11 | 0.492 |
| AST (IU/L) | 23.3 ± 8.3 | 28.7± 8.2 | 26.5 ± 5.1 | 0.088 |
| Creatinine (mg/dL) | 0.81 ± 0.36 | 1.03 ± 0.27 | 0.97 ± 0.28 | 0.085 |
| WBC (× 109) | 6.9 ± 1.2 | 7.1 ± 2.1 | 7.0 ± 2.2 | 0.230 |
| Lymphocytes (%) | 22.3 ± 4.2 | 24.3 ± 3.8 | 23.98 ± 4.8 | 0.156 |
a
P < 0.05 vs healthy controls and non cachexia;
c
P < 0.05 vs healthy controls.